2010 Metabolic Syndrome
-
Upload
sex-gender-womens-health-collaborative -
Category
Documents
-
view
219 -
download
0
Transcript of 2010 Metabolic Syndrome
-
7/31/2019 2010 Metabolic Syndrome
1/48
METABOLIC SYNDROME
Nature, Nurture, NutritionGenomics, Proteomics,
Metabolomics
-
7/31/2019 2010 Metabolic Syndrome
2/48
Janice Werbinski, M.D., FACOG
Gynecologist -Borgess Womens Health
Former Medical Director -BMH Womens Center
Associate Clinical Professor - MSU / CHM
Author, Curriculum, Womens Health Track,
Internal Medicine Residency, MSU/KCMS
Founding President, ACWHPConsultant/Metabolic Syndrome Program
Borgess Integrative Medicine
-
7/31/2019 2010 Metabolic Syndrome
3/48
CLASSIC DEFINITIONSyndrome X (Dr. G. Reaven)
High Blood Pressure (>130/85)
High Blood Fats (Triglyceride) (>150)
Low HDL (Good) Cholesterol (110 mg/dl)
Increased Waist to Hip Ratio (>35 waist)
Central Obesity-Inability to Lose Weight
Family History of DM, HTN, CVD,Obesity
-
7/31/2019 2010 Metabolic Syndrome
4/48
FUNCTIONAL MEDICINEDEFINITION
Metabolic Syndrome
An age-related functional disorder of
glucose metabolism, mediated byaltered genetic expression at the cell
membrane level, and manifested under
particular environmental conditions.
-Dan Lukaczer, ND
Institute for Functional Medicine
-
7/31/2019 2010 Metabolic Syndrome
5/48
Alternative Labels
Syndrome X
Metabolic SyndromeInsulin Resistance
Pre-Diabetes
Glucose Intolerance
-
7/31/2019 2010 Metabolic Syndrome
6/48
INCIDENCE
Up to 25% of Americans (47,000,000 in US)
50% May not be Obese
Increasing in Children and AdolescentsIncreasing in Industrialized Nations
Very Close Association with:
-Diabetes-Cardiovascular Disease
-PCOS
-Preeclampsia / Eclampsia
-
7/31/2019 2010 Metabolic Syndrome
7/48
LABORATORY
PARAMETERSFasting Glucose & Insulin
2 hour Glucose & Insulin after 75gm glucola
Lipid panel
Homocysteine
Thyroid panelCRP
Euglycemic Clamp Studies (Research)
-
7/31/2019 2010 Metabolic Syndrome
8/48
CAUSES
1. GENETIC PREDISPOSITION (Genomics)
2. STANDARD AMERICAN DIET (SAD) Processed Foods, Preservatives, Additives
Low-and No-Fat Foods (High Carb) The Food Pyramid (High Carb)
Trans- and Saturated Fats
Low in Essential Nutrients and Fiber
High Fructose Corn Syrup and Soda3. SEDENTARY LIFESTYLE
4. GLUTEN AND DAIRY INTOLERANCE common
-
7/31/2019 2010 Metabolic Syndrome
9/48
Does Nutrigenomics Play a Role?
-
7/31/2019 2010 Metabolic Syndrome
10/48
-
7/31/2019 2010 Metabolic Syndrome
11/48
RESULTING SYNDROMES
Classic presentation
CAD
CVA
HyperlipidemiaHypertension
DM
Obesity
Cancer
PCOS
-
7/31/2019 2010 Metabolic Syndrome
12/48
-
7/31/2019 2010 Metabolic Syndrome
13/48
CLASSIC APPROACH(KNEE-JERK)
Missing the Forest for theTrees
-
7/31/2019 2010 Metabolic Syndrome
14/48
Traditional Allopathic Approach
Abnormal Parameter, Symptom, or LaboratoryBlood Values: GTT, or 2 hr Postprandial Glucose
LDL Cholesterol
Blood Pressure
High BMI
Mood Disorders
GERD
Fibromyalgia/ Chronic Fatigue Syndrome
Signs of PCOS
IBS
-
7/31/2019 2010 Metabolic Syndrome
15/48
Knee-Jerk Reaction
Diabetic Meds
Antihypertensives
Statins
AnalgesicsOCs/Progestins
Antidepressants
Proton pump inhibitors
Anorexics
Bariatric Surgery
-
7/31/2019 2010 Metabolic Syndrome
16/48
WHY TRADITIONAL
APPROACH FAILSPatient has intense CHO cravings diet &medications alone do not lessen the cravings
Patients worry about the multiple symptoms, thinking
their body is becoming alien - need emotional support& education of this multidimensional condition
Medications are prescribed to treat a prevalentsymptom or disease, not the global assimilation ofsymptoms
Poly-pharmacy increases drug interaction, cost, sideeffects, & non-compliance
Patients ask for a holistic model due to multiplesymptoms
Patients want to be FUNCTIONAL again
-
7/31/2019 2010 Metabolic Syndrome
17/48
-
7/31/2019 2010 Metabolic Syndrome
18/48
NUTRITIONAL APPROACH
Kalamazoo Heart Center of
Excellence:Metabolic Syndrome
Program
-
7/31/2019 2010 Metabolic Syndrome
19/48
THE CASE FOR NUTRITIONALTHERAPIES
This disorder does not result from a lack of
prescription drugs
There is no magic bullet
Many end up taking 4 or more drugs then
dealing with an array of side effects
Drugs merely treat a symptom or lab valuewhile allowing the underlying disease
process to continue
-
7/31/2019 2010 Metabolic Syndrome
20/48
TREATMENT PLANOnce diagnosis is made:
Assess any medical problems
Psychophysiological assessment: meet the patient in
theirmoment with all of their symptomsSet up Primary and Secondary goals together withthe patient
Nutritional Supplement Recommendations
40-30-30 Macronutrient PlanLifestyle Modification Discussion
F/U at 3 wks, 8 wks, 3 mos, 6 mos, 9 mos, 12 mos
Group Classes for Health Education
-
7/31/2019 2010 Metabolic Syndrome
21/48
PROGRAM GOALS
Appropriate Calories to Ideal Weight
Increase Omega-3 Oils
Increase MonoUnsaturated (Mediterranean) Fat
Low Saturated and Trans Fatty Acids
Low Glycemic Index Foods
High Fiber
Low simple CHO (increase complex CHO)
Moderate Protein
-
7/31/2019 2010 Metabolic Syndrome
22/48
-
7/31/2019 2010 Metabolic Syndrome
23/48
NUTRICEUTICAL
TREATMENTDIET IN GENERAL:
Mediterranean
30% Protein
30% Good Fats (monounsaturated)
40% Low Glycemic Index Carbs
Soy
High in Soluble Fiber
Micronutrients
-
7/31/2019 2010 Metabolic Syndrome
24/48
NUTRICEUTICAL
MODE OF ACTIONOMEGA - 3 FATS (EPA/DHA)-Cell Wall and
Receptor Function
a LIPOIC ACID -Mimics InsulinMG -Needed for release of Insulin
CHROMIUM -Increases function of insulin
VANADIUM -Mimics insulin (>100mg toxic)gamma LINOLEIC ACID-Restores insulin
function. Restores nerve function
FIBER -Slows Glu absorption in GI Tract
-
7/31/2019 2010 Metabolic Syndrome
25/48
MODE OF ACTION
Pharmaceutical vs. Nutriceutical
ENHANCEDINSULINSECRETION
SLOWED
GLUCOSE
ABSORPTION
REDUCEDGLUCOSEPRODUCTION
PERIPHERAL
GLUCOSEDISPOSAL
IMPROVEDRECEPTORFUNCTION
PHARMA
CEUTICAL
Sulfonylurea
(Micronase)
Meglitinides
(Prandin)
Alpha-
Glycosidase
Inhibitors
(Acarbose)
Biguanides
(Metformin)
Thiazolidine-
diones
(Actos)
Thiazolidine-
diones
(Actos)
NUTRI
CEUTICAL
Magnesium
Vanadium
SolubleFiber
Complex
Carbs
Protein
Complex
Carbs
Protein
Fiber
PUFA
Lipoic Acid
Linoleic Acid
PUFA
Omega-3
Vanadium
-
7/31/2019 2010 Metabolic Syndrome
26/48
Recommended Nutrients
EPA 1500-4000 MG
DHA 1000-2000MG
Mg 200-400 mg
Cr 400-1000 ugVd 15-50 mg
CLA 1000-3000 mg
Vit E 400-800 U
Vit C 2-6 gm
aLA 50-200 mg
Arg 2 gm
-
7/31/2019 2010 Metabolic Syndrome
27/48
GOOD CARBS
GLYCEMIC INDEX
Volunteers blood sugar response to a test food
containing 50 gm carbohydrate, as compared to
50 gm pure glucose (3 Tbs)
HIGH >70%
MODERATE 55-66%LOW 40-54%
VERY LOW
-
7/31/2019 2010 Metabolic Syndrome
28/48
-
7/31/2019 2010 Metabolic Syndrome
29/48
Foods that Lower I.R.
Rice (esp. high amylose starch)
Soluble Fiber (slows glucose absorption)
Vegetable Protein (modulate GLUT-4transport)
Complex CHO (slowly digested, prevents
rapid change in glucose and insulin)
-
7/31/2019 2010 Metabolic Syndrome
30/48
Foods to Avoid
Refined CHO (Glycemic Index)
Simple Sugars -High Fructose Corn Syrup
White bread and flourJuices
Sugar-containing Soda
Processed FoodsTrans Fats
Saturated Fats
-
7/31/2019 2010 Metabolic Syndrome
31/48
GOOD FATS
Monounsaturated, Mediterranean (olive)
Omega-3 Fatty Acids (Fish Oils, Flaxseed)Conjugated Linoleic Acid (PPAR agonist,
acts like TZDs)
Alpha Lipoic Acid (Antioxidant)
-
7/31/2019 2010 Metabolic Syndrome
32/48
FATS AND HEART DISEASE
Saturated Fat Diet
Finland
US
Monounsaturated Fat
Italy Greece
Low Total Fat
Japan
-
7/31/2019 2010 Metabolic Syndrome
33/48
Shopping Tips
AVOID THE CENTER AISLES AT THE
SUPERMARKET
SHOP MAINLY IN THE PERIMETER
AREAS:
Fresh Produce
Fruits and Vegetables
Meats and Eggs
+/- Frozen Foods
-
7/31/2019 2010 Metabolic Syndrome
34/48
-
7/31/2019 2010 Metabolic Syndrome
35/48
UNHEALTHY DIET
Refined CHO is absorbed rapidly and
triggers release of excess insulin
Diminished insulin signal impedes fusion of
transport channel vesicles with cell
membrane
Insulin signal is diminished by
Phosphotyrosine, TNF alpha, cytokines,NF-kappa, inflammatory substances
-
7/31/2019 2010 Metabolic Syndrome
36/48
-
7/31/2019 2010 Metabolic Syndrome
37/48
HEALTHY DIET ANDMICRONUTRIENTS
Complex CHO more slowly absorbed inintestine appropriate insulin released
(Soy, Amylose Starch, fiber)
Insulin signal supported by: Vn, Cr, CLA,Lipoate, Inositol, Mg, Vit E
Strong insulin signal directs sugar transport
vesicle to fuse with cell wallCLA binds to nucleus to support gene
expression
-
7/31/2019 2010 Metabolic Syndrome
38/48
GOALS
Work closely with PCP
Approach chronicdiseases by addressingunderlying functional problems
Formulate a viable program for the
prevention of disease
-
7/31/2019 2010 Metabolic Syndrome
39/48
CONCLUSIONCorrection of lab values does not
constitute wellness
Lifestyle intervention REQUIRESimmediate positive effects & education
for optimal change and management.
The healing process needs: support,love, hope & humor
-
7/31/2019 2010 Metabolic Syndrome
40/48
END
-
7/31/2019 2010 Metabolic Syndrome
41/48
CASE PRESENTATIONS
Metabolic Syndrome
Insulin ResistanceSyndrome X
C St d PCOS
-
7/31/2019 2010 Metabolic Syndrome
42/48
Case Study - PCOS
(Rebecca)31 y.o. Woman with:
Anxiety
PMS and MoodinessFatigue
Amenorrhea
Sleep Disorder
-
7/31/2019 2010 Metabolic Syndrome
43/48
PCOS (Rebecca)
October 31Glucose
FBS 93
2 hr 112
Insulin
Fasting 12
2 hr 108
Cholesterol 271
HDL 39LDL 178
Triglyceride 269
Weight 165
Menses absent
December 21Glucose
FBS 91
2 hr 83
Insulin
Fasting 9
2 hr 17
Cholesterol 200
HDL 45LDL 141
Triglyceride 71
Weight 153
Menses regular
C St d PMS F ti
-
7/31/2019 2010 Metabolic Syndrome
44/48
Case Study PMS, Fatigue
(Martha)54 y.o. Woman with:
Anxiety
Irritable Bowel SymptomsAdrenal Fatigue
Fibromyalgia
No weight loss with low fat diet, exercise
-
7/31/2019 2010 Metabolic Syndrome
45/48
Fatigue, FMA (Martha)
November 8
Glucose
FBS 114
2 hr 209
Insulin
Fasting 9
2 hr 87
Cholesterol 204
HDL 77LDL 111
Triglyceride 78
Weight 189
TSH 3.94 (2/13/02)
February 21
Glucose
FBS 104
2 hr 92
Insulin
Fasting 7
2 hr 25
Cholesterol
HDL 70LDL 97
Triglyceride 84
Weight 169
-
7/31/2019 2010 Metabolic Syndrome
46/48
-
7/31/2019 2010 Metabolic Syndrome
47/48
PHARMACEUTICAL
SIDE EFFECTSSU - hypoglycemia, weight gain,
hyperinsulinemia
Non-SU Secretagogues - same, plus3/day dosing
Biguanides - GI upset, lactic acidosis
a-Glucosidase Inhib - GI upset, 3/daydose
Thiazolidinediones - LFT, weight gain,
edema, slow onset of action
-
7/31/2019 2010 Metabolic Syndrome
48/48
METABOLIC SYMPTOMS
AND SYNDROMESSymptoms:Weakness/Fatigue
Muscle Pain
Diarrhea/ConstipationStomach Irritation
Sleep Problems
Allergy Symptoms
Inability to Lose Wt
Immune Problems
Hypoglycemia
Syndromes:
Chronic Fatigue
FibromyalgiaIrritable Bowel
Syndrome
SomatizationPMS/PCOS
Mood Disorders
Chronic Yeast